Treatment guidelines for HIV-infected pregnant and breastfeeding women have shifted in recent years towards lifelong maternal cART. These changes have led to important reductions in MTCT and are expected to improve maternal HIV outcomes. However, the increasing use of cART during pregnancy has led to challenges. cART's role in causing adverse pregnancy outcomes has been of concern, as has improving postpartum retention in care. In Aim 1a, we evaluated duration of cART during pregnancy's association with LBW due to growth restriction. We found no evidence of an increased risk of LBW for women receiving cART for <8 weeks (RR 1.22, 95% CI: 0.77, 1.91), 9-20 weeks (RR 1.23, 95% CI: 0.82, 1.83), or 21-36 weeks (RR 0.87, 95% CI: 0.22, 3.46), comp...
To describe pregnancy outcomes among HIV-infected women and examine factors associated with live bir...
To describe pregnancy outcomes among HIV-infected women and examine factors associated with live bir...
OBJECTIVE: To assess the association between timing of maternal combination ART (cART) initiation an...
Treatment guidelines for HIV-infected pregnant and breastfeeding women have shifted in recent years ...
To estimate the association between duration of combination antiretroviral therapy (cART) during pre...
To estimate the association between duration of combination antiretroviral therapy (cART) during pre...
Access to lifelong combination antiretroviral therapy (cART) is expanding among HIV-infected pregnan...
Access to lifelong combination antiretroviral therapy (cART) is expanding among HIV-infected pregnan...
Background The benefits of combination anti-retroviral therapy (cART) in HIV-positive pregnant women...
Background The benefits of combination anti-retroviral therapy (cART) in HIV-positive pregnant women...
The benefits of combination anti-retroviral therapy (cART) in HIV-positive pregnant women (improved ...
Background The benefits of combination anti-retroviral therapy (cART) in HIV-positive pregnant women...
textabstractBackground The benefits of combination anti-retroviral therapy (cART) in HIV-positive pr...
Background: Malawi launched Option B+ in July 2011, a program for all pregnant or breastfeeding HIV-...
Masters of Public Health - see Magister Public HealthIntroduction: Mother-to-child transmission (MTC...
To describe pregnancy outcomes among HIV-infected women and examine factors associated with live bir...
To describe pregnancy outcomes among HIV-infected women and examine factors associated with live bir...
OBJECTIVE: To assess the association between timing of maternal combination ART (cART) initiation an...
Treatment guidelines for HIV-infected pregnant and breastfeeding women have shifted in recent years ...
To estimate the association between duration of combination antiretroviral therapy (cART) during pre...
To estimate the association between duration of combination antiretroviral therapy (cART) during pre...
Access to lifelong combination antiretroviral therapy (cART) is expanding among HIV-infected pregnan...
Access to lifelong combination antiretroviral therapy (cART) is expanding among HIV-infected pregnan...
Background The benefits of combination anti-retroviral therapy (cART) in HIV-positive pregnant women...
Background The benefits of combination anti-retroviral therapy (cART) in HIV-positive pregnant women...
The benefits of combination anti-retroviral therapy (cART) in HIV-positive pregnant women (improved ...
Background The benefits of combination anti-retroviral therapy (cART) in HIV-positive pregnant women...
textabstractBackground The benefits of combination anti-retroviral therapy (cART) in HIV-positive pr...
Background: Malawi launched Option B+ in July 2011, a program for all pregnant or breastfeeding HIV-...
Masters of Public Health - see Magister Public HealthIntroduction: Mother-to-child transmission (MTC...
To describe pregnancy outcomes among HIV-infected women and examine factors associated with live bir...
To describe pregnancy outcomes among HIV-infected women and examine factors associated with live bir...
OBJECTIVE: To assess the association between timing of maternal combination ART (cART) initiation an...